Legal
Accessibility
We build for everyone in the NET community — including people using assistive technology, on treatment, or with low vision.
Last updated 1 May 2026.
Our commitment
Our patient audience includes people who are newly diagnosed, fatigued, on treatment, using assistive technology, or supporting a loved one. We design and build to WCAG 2.1 AA on priority pages — the Knowledge Hub, donation flow, patient-support flow, and account area.
What we do
Semantic HTML, focus-visible outlines, sufficient colour contrast (4.5:1 for body text), keyboard-navigable forms with proper labels, alt text on imagery, screen-reader-friendly icon labelling, and reduced-motion handling. We avoid colour-only signalling and dark patterns.
Known gaps
Some legacy patient-story content from our old site has placeholder images that aren't yet annotated. Some embedded videos rely on YouTube's captions which we're auditing for accuracy. PDFs in the Knowledge Hub are scanned for tagged-PDF compliance — older booklets may not yet meet that bar; flag them and we'll prioritise a re-tag.
Report a barrier
If you hit a page that doesn't work for you — anything from contrast to a broken keyboard flow to a clinical PDF you can't read with a screen reader — email info@neuroendocrinecancer.org.nz with the URL and what you were trying to do. We treat accessibility issues as priority bugs and aim to come back within 5 working days.
Standards we work to
WCAG 2.1 AA (Web Content Accessibility Guidelines) for the website. NZ Government Web Accessibility Standard 1.1 as a reference. We test with VoiceOver (macOS, iOS), TalkBack (Android) and NVDA (Windows) on the priority flows.
Updates
This statement will be updated when we make material accessibility changes. The site itself is iterated on continuously — last accessibility review: 1 May 2026.
Found a barrier? Email info@neuroendocrinecancer.org.nz with the URL and what you were trying to do. Read also the Privacy and Terms.